Yarrow Bioscience IncYARW
▲ ポジティブ資本関連度
VYNE declares a special dividend contingent on merger closing, providing a direct cash return to shareholders.
銘柄への影響 1
Biotech & Genomic Medicine
Yarrow Bioscience Incテーマインパクト
カバレッジ外企業 1
Yarrow Bioscience非上場± 混在
資本関連度
Yarrow is the merger partner; the dividend is paid by VYNE, not Yarrow, but the merger is a key event for Yarrow.